---
share: "true"
BOX:
  - ê°•ì˜ë¡
í•™ê¸°:
  - "08"
ê³¼ëª©:
  - ë‚´ê³¼í•™1
íŒ€í‹°ì¹­: í˜„ë‚´
ì°¨ì‹œ: 6-7ì£¼ì°¨
ì§„í–‰ë¥ : 
tags:
  - 08ì¤‘ê°„
ì§„í–‰ë„: 70%
---
# Urinary tract infections (ë¹„ë‡¨ê¸°ê³„ ê°ì—¼ì¦)
# 1. Introduction

>[!check]- Urinary tract (ë¹„ë‡¨ê¸°ê³„)
>![[Urinary tract - í•´ë¶€í•™#Urinary tract(ë¹„ë‡¨ê¸°ê³„)ì˜ êµ¬ì„±|Urinary tract - í•´ë¶€í•™ > Urinary tract(ë¹„ë‡¨ê¸°ê³„)ì˜ êµ¬ì„±]]

## (1) Defense mechanisms of urinary tract

| Defense mechanism       |                                                                                                                                            |
| ----------------------- | ------------------------------------------------------------------------------------------------------------------------------------------ |
| Normal urination        | - Adequate flow<br>- Complete, frequent voiding (ë°°ë‡¨) : ì„¸ê·  ì •ì²´ ì—†ì´ ì œê±°                                                                         |
| Anatomical structures   | - **Lengt**h of urethra<br>- **Urethral high pressure** zone : ìš”ë„ê·¼ìœ„ë¶€ ì£¼ë¦„ íŒ½ì°½ìœ¼ë¡œ ì••ë ¥ ìƒìŠ¹<br>- Urethral peristalsis                               |
| Antimicrobial urine     | - **High urea content**<br>- **Low urine pH** : ê·  ì„±ì¥ ì–µì œ<br>- **Osmolarity**<br>- Organic acids<br>- Tamm-Horsfall protein                  |
| Mucosal defence barrier | - **Balanced distal urethra microflora**<br>- **Surface IgA antibodies**<br>- Glycosaminoglycan layer<br>- Exfoliation of urothelial cells |
- ì´ëŸ¬í•œ ë°©ì–´ ì²´ê³„ê°€ ê¹¨ì§€ë©´ ê°ì—¼ì— ì·¨ì•½í•´ì§.
## (2) Definition

- ì™¸ë¶€ í™˜ê²½ì—ì„œ bacteriaê°€ urethra(ìš”ë„)ë¡œ ë“¤ì–´ê°€, ì‹ ì²´ì˜ ë©´ì—­ ë°©ì–´ ì²´ê³„ë¥¼ ê¹¨ëœ¨ë¦¬ê³  uniray tract(ë¹„ë‡¨ê¸°ê³„)ì— ê°ì—¼ì„ ìœ ë°œí•œ ìƒíƒœ.<br>(Conditions that happen when bacteria from the external environment enter the urethra, evade the body's immune defenses and cause urinary tract infection)

![[Pasted image 20241016140116.png|UTIì˜ ë¶„ë¥˜|350]]

| UPPER urinary tract infection (ìš”ê´€) |                       |
| ---------------------------------- | --------------------- |
| Kidney infection                   | Pyelonephritis (ì‹ ìš°ì‹ ì—¼) |
| Ureter infection : ë‹¨ë… ë°œìƒ ì ìŒ        | Ureteritis (ìš”ê´€ì—¼)      |

| **LOWER urinary tract infection (ìš”ë„)** |                    |
| -------------------------------------- | ------------------ |
| Bladder infection : ì••ë„ì ìœ¼ë¡œ ë§ìŒ           | **Cystitis (ë°©ê´‘ì—¼)** |
| Urethra infection : ë‹¨ë… ë°œìƒ ì ìŒ           | Urethritis (ìš”ë„ì—¼)   |

## (3) Predisposition, incidence, risk factor
- **ê°œ**ì—ì„œëŠ” **5-27%** ë¡œ í”í•¨ / ê³ ì–‘ì´ì—ì„œëŠ” <2%

| ê°œì—ì„œì˜ predisposition & incidence                           |
| --------------------------------------------------------- |
| Female > Male                                             |
| 2ì‚´ ì´í•˜ë‚˜ 6ì‚´ ì´ìƒì—ì„œ ë§ì´ ë°œìƒ                                      |
| í˜¸ë°œ í’ˆì¢…ì€ ë”°ë¡œ ì—†ìŒ                                              |
| DM(Diabetes mellitus) ë˜ëŠ” hyperadrenocorticism í™˜ìì˜ 41.6%ì—ì„œ |
| Long-term glucocorticoids ì ìš© ì‹œ 18-39%ì—ì„œ                   |
| **ê³ ì–‘ì´ì—ì„œëŠ”..**                                              |
| 10ì‚´ ì´ìƒì—ì„œ ë§ì´ ë°œìƒ                                            |
| Risk factor : Persian í’ˆì¢…, females, ë‚˜ì´ë“¦, ì²´ì¤‘ ê°ì†Œ             |
| í˜¹ì€ ì–´ë¦° ë‚˜ì´ì—ë„ ìš”ë¡œê³„ ìê·¹ì´ ì§€ì†ë˜ë©´ ë°œë³‘ ê°€ëŠ¥ (ìš”ì¹´í…Œí„°, ìˆ˜ìˆ  ë“±)                |
| CKDì˜ 17-30%, DMì˜ 12-13%, Hyperthyroidismì˜ 12-22%ì—ì„œ        |
>[!tldr]- Uropathogens (ê°ì—¼ì²´)
> - ì•„ë˜ 10ê°€ì§€ê°€ ê°œì—ì„œ UTI ê°ì—¼ì˜ 95-97%ë¥¼ ì°¨ì§€
> 	- ***Escherichia coli*** (50%)
> 	- *Staphylococcus*, *Streptococcus*, *Enterococcus* : ê·¸ëŒì–‘ì„±ê· 
> 	- *Proteus*, *Klebsiella*, *Pasteurella*, *Enterobacter*, *Pseudomonas*
> 	- *Mycoplasma*
> - ê³ ì–‘ì´ì—ì„œëŠ”..
> 	- ***Escherichia coli*** (47%)
> 	- *Staphylococcus* (18%)
> 	- *Streptococcus* (13%)
> 	- *Klebsiella* (4%)
> - ë‹¨ì¼ ê°ì—¼ì´ ê°€ì¥ í”í•¨(75%)
> - female dogsì—ì„œ multiple organism infectionì´ í”íˆ ê´€ì°°ë¨.

# 2. ë¶„ë¥˜
## (1) Classification of Bacterial cystitis (ì„¸ê· ì„± ë°©ê´‘ì—¼ì˜ ë¶„ë¥˜)

> - **Uncomplicated UTI** = **Sporadic bacterial cystitis** (ì‚°ë°œì„± ì„¸ê· ì„± ë°©ê´‘ì—¼) : ê±´ê°•í•œ ê°œì²´ì—ì„œ ì‚°ë°œì /ì¼ì‹œì ìœ¼ë¡œ ë°œìƒ
> - **Complicated UTI** : ì§€ì†ì , ì¬ë°œì„± ê°ì—¼, ì¹˜ë£Œ ì‹¤íŒ¨ë¡œ ì´ì–´ì§ˆ ìˆ˜ ìˆìŒ.
> 	- **Recurrent UTI** : 1ë…„ ë™ì•ˆ 3íšŒ ì´ìƒ ì¬ë°œ
> 		- ==**Relapsing** (ì¬ë°œ) : ì™„ì „íˆ ì¹˜ë£Œë˜ì—ˆëŠ”ë°, ë˜‘ê°™ì€ ê°ì—¼ì²´ì— ì˜í•´ ì¬ë°œ (ê°ì—¼ì›ì˜ ì”ì¡´)==
> 		- **Persistent** (ì§€ì†ê°ì—¼) : ì¹˜ë£Œí–ˆìœ¼ë‚˜, ì§€ì†ì ìœ¼ë¡œ ì„¸ê·  ê´€ì°°ë¨ (ìˆ™ì£¼ ë©´ì—­ ë¬¸ì œ, í•­ìƒì œ ë‚´ì„±ê· )
> 		- **Reinfection** (ì¬ê°ì—¼) : ìƒˆë¡œìš´ ê°ì—¼ì²´ì— ì˜í•´ ìœ ë°œ 
> 		- **Refractory** : ì¹˜ë£Œ ë°˜ì‘ ì—†ìŒ - ì¦ìƒ ê°œì„  X, ì„¸ê·  ì‚¬ë©¸ X
> - **Subclinical bacteriuria** (asymptomatic bacteriuria) : ì„ìƒì¦ìƒ(LUTS, lower urinary tract signs)ì€ ì—†ì§€ë§Œ ê·  ê²€ì¶œ

>[!tldr] Complicated UTIì˜ ìš”ì¸
> - í•´ë¶€í•™ì  ìš”ì¸ : ectopic ureters(ì´ì†Œì„± ìš”ê´€), ureteroceles(ìš”ê´€ë¥˜)
> - ì „ì‹  ì§ˆí™˜ : DM, hyperthyroidism, HAC(ë¶€ì‹ í”¼ì§ˆê¸°ëŠ¥í•­ì§„ì¦), systemic neoplasia, immunocompromised(ë©´ì—­ì €í•˜)
> - ë¹„ë‡¨ê¸°ê³„ ìì²´ ë¬¸ì œ : urolithiasis(ìš”ë¡œê²°ì„), cystic neoplasia(ë°©ê´‘ì¢…ì–‘), deep seated bacterial cystitis(ì‹¬ì¸µ ì„¸ê· ì„± ë°©ê´‘ì—¼)

## ğŸŸ¡ Pyelonephritis (ì‹ ìš°ì‹ ì—¼)

- **Acute pyelonephritis (APN)** : ë³´í†µ ì„¸ê· ì´ í•˜ë¶€ ìš”ë¡œì—ì„œ ì½©íŒ¥ê¹”ë•Œê¸°(renal pelvis), ì½©íŒ¥ ì‹¤ì§ˆ(parenchyma)ë¡œ ì˜¬ë¼ê°€ë©´ì„œ ë°œìƒ. ë©°ì¹ ~ëª‡ ì£¼ ë‚´ë¡œ ë°œë³‘. ê°€ë” í˜ˆí–‰ì„±(hematogenous)ìœ¼ë¡œë„ ë°œìƒí•¨.
	- **Complicated APN** : DM, ì¢…ì–‘, ë©´ì—­ì €í•˜, í•´ë¶€í•™ì  ë¬¸ì œ ë“± ì „ì‹  ì§ˆí™˜ê³¼ í•¨ê»˜ ë‚˜íƒ€ë‚˜ëŠ” ê²½ìš°
	- **Noncomplicated APN** <br>

![[Pasted image 20241016191119.png|250]]
## ğŸŸ¡ Bacterial prostatitis (ì„¸ê· ì„± ì „ë¦½ì„ ì—¼)
- ì„±ìˆ™í•œ ìˆ˜ì»· ê°œì—ì„œ ì£¼ë¡œ ë°œìƒí•˜ë©°, ë§Œì„± ë˜ëŠ” ê¸‰ì„±ìœ¼ë¡œ ë‚˜íƒ€ë‚¨.
	- Bacterial cystitisë„ í•¨ê»˜ ë™ë°˜í•  ë•Œê°€ ë§ìŒ.
	- ì „ë¦½ì„  ë†ì–‘ìœ¼ë¡œ ì§„í–‰ë˜ë©´ íŒŒì—´ê³¼ ê°™ì€ ì‹¬ê°í•œ ì§ˆë³‘ì„ ì´ˆë˜í•  ìˆ˜ ìˆìŒ.

| DDx                                                                                            |
| ---------------------------------------------------------------------------------------------- |
| Prostatic neoplasia (ì „ë¦½ì„  ì¢…ì–‘)                                                                   |
| Prostatic cyst (ì „ë¦½ì„± ë‚­ì¢…)                                                                        |
| Prostatic hyperplasia (ì „ë¦½ì„  ë¹„ëŒ€ì¦)                                                                |
| Perirectal mass (ì§ì¥ì£¼ìœ„ ì¢…ì–‘)                                                                      |
| Periprostatic mass (ì „ë¦½ì„ ì£¼ìœ„ ì¢…ì–‘)                                                                  |
| Disease causing tenesmus (ì´ê¸‰í›„ì¦; í•­ë¬¸ ë¶ˆì™„ì „ ë°°ë³€ê° ìœ ë°œ ì§ˆí™˜)<br>  - e.g) large intestinal disease (ëŒ€ì¥ ì§ˆí™˜) |

# 3. ì„ìƒì  íŠ¹ì§•

| Clinical features                                                                                                   |                                                     |
| ------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------- |
| Typical **LUTS (lower urinary tract signs)**                                                                        |                                                     |
|   : stranguria(í†µì¦ë°°ë‡¨), hematuria(í˜ˆë‡¨), pollakuira(ë¹ˆë‡¨), periuria(ì´ìƒë°°ë‡¨; ë‹¤ë¥¸ ê³³ì— ì†Œë³€), dysuria(ë°°ë‡¨í†µ)                         | (ì–´ë¦° ê³ ì–‘ì´ì˜ ê²½ìš°<br>feline idiopathic cystitis<br>ë¨¼ì € ì˜ì‹¬) |
| Excessive licking (ê³¼ë„í•œ í•¥ìŒ)                                                                                          | ë°©ê´‘ì—¼(cystitis)                                       |
| Abdominal pain (ë³µë¶€ í†µì¦)                                                                                              | ì‹ ìš°ì‹ ì—¼, ì „ë¦½ì„ ì—¼ â†‘                                        |
| ë°œì—´, ì‹ìš•ë¶€ì§„, ê¸°ë ¥ì €í•˜, êµ¬í† , PUPD                                                                                            | ê¸‰ì„± ì‹ ìš°ì‹ ì—¼(APN)                                        |
| ë°œì—´, ì‹ìš•ë¶€ì§„, ê¸°ë ¥ì €í•˜, êµ¬í† <br>+ preputial edema, hindlimb edema, tenesmus(ì´ê¸‰í›„ì¦),<br>Purulent/hemorrhagic uretheral disharge | ê¸‰ì„± ì „ë¦½ì„ ì—¼(acute prostatitis)                          |


# 4. ì§„ë‹¨

| ê¸°ì¤€                     |                                                                                   |
| ---------------------- | --------------------------------------------------------------------------------- |
| Signalment             | - APN(ê¸‰ì„±ì‹ ìš°ì‹ ì—¼) : Boxer<br>- Prostatitis(ì „ë¦½ì„ ì—½) : ì„±ìˆ™ ìˆ˜ì»·, í‰ê·  7-11ì„¸                    |
| ë¬¸ì§„ ì²­ì·¨                  | ê¸°ì €ì§ˆí™˜ ìœ ë¬´, ì¬ë°œ ì—¬ë¶€ ë“±                                                                  |
| ì‹ ì²´ ê²€ì‚¬                  | ë³µë¶€ ì´‰ì§„, ì§ì¥ ì´‰ì§„, í”¼ë¶€ ê²€ì‚¬, digital vaginal ê²€ì‚¬ (ì§ˆ, ì™¸ìŒë¶€ ê°ì—¼ ìˆëŠ”ì§€)                           |
| ã„´ cycstitis (ë°©ê´‘ì—¼)      | - ì‘ê³ , ë¹ˆ ë°©ê´‘ / ë°©ê´‘ë²½ ë¹„í›„ (\*ë“œë¬¼ê²Œ ê²°ì„, ì¢…ì–‘ ë“±ìœ¼ë¡œ ë°©ê´‘ ë¹„ëŒ€)<br>- caudal abdominal or lumpar pain |
| ã„´ APN (ê¸‰ì„± ì‹ ìš°ì‹ ì—¼)        | - flank, abdominal, sublumbar pain<br>- kidney failure(ì‹ ë¶€ì „)ìœ¼ë¡œ ë°œì „í•  ê°€ëŠ¥ì„±             |
|   ã„´ Prostatitis (ì „ë¦½ì„ ì—¼) | - ì „ë¦½ì„ ì˜ ë¹„ëŒ€ì¹­ í™•ì¥, ê³ í†µ (\*ë“œë¬¼ê²Œ ì–‘ì¸¡ì„±, ë¹„ëŒ€ë˜ì§€ ì•Šì„ ìˆ˜ ìˆìŒ)<br>- preputial, hindlimb edema        |
## Urinalysis

- ê°€ì¥ ì´ìƒì ì¸ ì±„ë‡¨ ë°©ë²•ì€ ë°©ê´‘ ì²œì.
- ë‡¨ ì¹´í…Œí„°ë¥¼ ì´ìš©í•´ì„œ ì±„ì·¨í•˜ê¸°ë„ í•¨.

| Urinalysis                                 |                                                                                                                                                                                                                             |
| ------------------------------------------ | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| ë¬¼ë¦¬ì  ê²€ì‚¬                                     | - í˜ˆë‡¨ and/or ë†ë‡¨<br>- USG(ìš”ë¹„ì¤‘)ì˜ variationì´ í¼<br>![[Pasted image 20241017005417.png\|300]]                                                                                                                                     |
| í™”í•™ì  ë¶„ì„                                     | - Dip-stickì—ì„œ í˜ˆë‡¨, ë‹¨ë°±ë‡¨                                                                                                                                                                                                       |
| UPC ratio                                  | - ì‹¬í•œ ë‹¨ë°±ë‡¨ê°€ í™•ì¸ëœ ê²½ìš° ì„ íƒì ìœ¼ë¡œ                                                                                                                                                                                                      |
| ì¹¨ì „ë¬¼ ê²€ì‚¬<br>(ìš”ì¹¨ì‚¬ ê²€ì‚¬)                         | - ì—¼ì¦ ì„¸í¬ : >5 WBC/400ë°° ì‹œì•¼<br>- ì„¸ê·  í™•ì¸ : ìˆ˜, ëª¨ì–‘, intra/extracellular, phagocytosis í™•ì¸ ë“±<br>- Wet ê²€ì‚¬ â†’ ê²°ì„, dryì—ì„œ í™•ì¸ë˜ì§€ ì•Šì€ ì´ìƒ ì„¸í¬, RBC ì‚°ì¬ ì •ë„<br>![[Pasted image 20241017005852.png\|228]] ![[Pasted image 20241017010216.png\|200]] |

## Urine culture

ë„ˆë¬´ ë§ì•„ì„œ ì‚´ì§ í¬ê¸°í–ˆì§€ë§Œ ì±„ìš¸ ê²ƒ

| **Urine culture** |                                                                                                                                                         |
| ----------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------- |
| ê¶Œì¥ë˜ëŠ” ìƒí™©           | - ê²½í—˜ì (empiric) ì¹˜ë£Œë¡œ ê°œì„ ë˜ì§€ ì•ŠìŒ<br>- ì¬ë°œì„±(recurrent) UTIs<br>- ê¸‰ì„± ì‹ ìš°ì‹ ì—¼(APN) : Nephropyelocentesis(ì‹ ìš°ì²œì), blood culture ê³ ë ¤<br>- ê¸‰ì„± ì „ë¦½ì„ ì—¼ : Prostateì˜ culture ê³ ë ¤ |
| ì†Œë³€ì˜ ì±„ì·¨ì™€ ì·¨ê¸‰        |                                                                                                                                                         |
| í•­ìƒì œ ê°ìˆ˜ì„± ê²€ì‚¬        |                                                                                                                                                         |
| ê²°ê³¼ í•´ì„ (ê·  ë™ì •)      |                                                                                                                                                         |
ì—¬ê¸° ì´í•˜ë„ ë³´ì¶© ì˜ˆì •.. ê±°ì˜ í•„ê¸°ë§Œ ìˆìŒ
## Routine laboratory tests

| Routine laboratory tests  |                     |
| ------------------------- | ------------------- |
| CBC                       | - Leukocytosis <br> |
| Serum biochemical profile | - Renal azotemia    |
## Imaging

| Radiographs _Cystitis                     |                                                    |
| ----------------------------------------- | -------------------------------------------------- |
| ![[Pasted image 20241016112244.png\|400]] | - ì‘ì€ í¬ê¸°ì˜ ë°©ê´‘<br>- ë°©ê´‘ë²½ì˜ ë¹„í›„(thickening), irregularity |

| Ultrasonography (Abd) _Cystitis           |                                                      |
| ----------------------------------------- | ---------------------------------------------------- |
| ![[Pasted image 20241017010957.png\|200]] | - ë°©ê´‘ë²½ ë¹„í›„<br>- bladder lumenì˜ Echogenic 0sediment<br> |

| Emphysematous(íê¸°ì¢…) cystitis               |                                                                                                                                            |
| ----------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------ |
| ![[Pasted image 20241017011128.png\|300]] | - E. coli, clostridium<br>- gas-producing bacteriaê°€ ë°©ê´‘ë²½ì— gas accumulation<br><br>(DM ìˆëŠ” í™˜ìì—ì„œ 33%, ì‹ ê²½ ì§ˆí™˜ ìˆëŠ” í™˜ìì—ì„œ 26%, ë¶€ì‹  ì§ˆí™˜ ìˆëŠ” í™˜ìì—ì„œ 19% ë°œìƒ) |

| Contrast radiography _Pyelonephritis      |                                                                |
| ----------------------------------------- | -------------------------------------------------------------- |
| ![[Pasted image 20241017011246.png\|300]] | - Mild to moderate pyelectasia<br>- Distortion of renal pelvis |

| Ultrasonography (Abd) _Pyelonephritis     |                                                                                                                                 |
| ----------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------- |
| -- ì‹¤ì§ˆì„ ëš«ì„ ê°€ëŠ¥ì„±ì´ ë†’ì•„ ì£¼ì˜.<br>ëŒ€ì‹  ---ë°©ë²•ì„ ì‚¬ìš©.    |                                                                                                                                 |
| ![[Pasted image 20241016112604.png\|300]] | - Renal pelvic dilation<br>- Blunting of the renal papilla<br>- Echogenic debris within the renal pelvis<br>- Ureteral dilation |


| Radiographs _Prostatitis                  |     |
| ----------------------------------------- | --- |
| ![[Pasted image 20241016112807.png\|300]] |     |

| Ultrasonography (Abd) _Prostatitis        |                                                                                                               |
| ----------------------------------------- | ------------------------------------------------------------------------------------------------------------- |
| ![[Pasted image 20241016112924.png\|300]] | - mildí•œ hyperechogenicity,<br>ì „ë¦½ìƒ˜ì˜ ë¹„ëŒ€(enlargement)ë¶€í„°<br>- mottled hyperechoic/hypoechoic íŒ¨í„´ê¹Œì§€<br>ì‹¬ê°í•œ ë¹„ëŒ€ê¹Œì§€ ë‹¤ì–‘í•¨ |
# 5. ì¹˜ë£Œ
- ë°©ê´‘ ì¢…ì–‘, í˜¸ë¥´ëª¬ ì§ˆí™˜ ë“± ë°°ì œí•˜ê³  ì‹œì‘. (í˜¹ì€ ê°™ì´ ê´€ë¦¬)
- ë©´ì—­ì–µì œ ì•½ë¬¼ì„ ì‚¬ìš©í•˜ëŠ” í™˜ìì—ì„œ, ë¹„ë‡¨ê¸°ê³„ì™€ í”¼ë¶€ ê°ì—¼ì— ì·¨ì•½

- **NSAIDs** : ì‹ ë…ì„± ì¡´ì¬, ìœ ì˜í•´ì„œ ì²˜ë°©.

### Subclinical bacteriuria
- ë¶ˆí•„ìš”í•œ í•­ìƒì œ ì²˜ë°©ë³´ë‹¤ëŠ”, ëª¨ë‹ˆí„°ë§ì´ ê¶Œì¥ë¨.

### Uncomplicate UTI
- ì í•©í•œ í•­ìƒì œë¥¼ ì²˜ë°©í•˜ë©´ ì´í‹€ ì•ˆì— ê°œì„ ì´ ë³´ì„.
- ì´ ê°œì„ ì´ ë³´ì´ì§€ ì•Šìœ¼ë©´ complicate UTIê±°ë‚˜, í•­ìƒì œë¥¼ ì˜ëª» ì¼ê±°ë‚˜.
- cytologyë¥¼ í–ˆì„ ë•Œ 3-5ì¼ í›„ë¶€í„° ê°œì„ ë¨.
- ë°©ê´‘ì—¼ í™˜ìì—ì„œ í•˜ë£¨ 1ë²ˆ ì•½ì„ ë¨¹ì´ëŠ” ê²½ìš°, ì €ë…ì— ë¨¹ì´ëŠ” ê²ƒì„ ê¶Œì¥í•¨. (ìˆ˜ë©´ ì‹œê°„ ë™ì•ˆ ì¶©ë¶„íˆ ì•½ë¬¼ ì‘ìš©í•  ìˆ˜ ìˆë„ë¡)

- ê²½í—˜ì  í•­ìƒì œë¥¼ ìš°ì„  ì²˜ë°©í•´ì•¼ í•˜ëŠ” ìƒí™©ë„ ìˆìŒ.
- Cytology â†’ ê°„ê· , ë‹¨ê°„ê· ì´ ë‹¤ìˆ˜ ê´€ì°°ëœë‹¤

|         |                                                           |                                                |
| ------- | --------------------------------------------------------- | ---------------------------------------------- |
| ê°„ê· , ë‹¨ê°„ê·  | E. coli,<br>Enterobacter,<br>Klebsiella,<br>Proteus, etc. | **Cephalosporins**<br>ìš°ì„ ì ìœ¼ë¡œ ê³ ë ¤                 |
| êµ¬ê·       | Staphylococcus,<br>Streptococcus,<br>Enterococcus, etc.   | **Amoxicillin**, **Cephalospotin**<br>ìš°ì„ ì ìœ¼ë¡œ ê³ ë ¤ |
- **Amoxicillin**
- **Trimethoprim-sulfamethoxazole** 
- Amoxicillin clavulanate
- Enrofloxacin : 1ë£¨ 1ë²ˆ ë³µìš© í€´ë†€ë¡  ì œì œ, ì¹¨íˆ¬ë ¥ì´ ë›°ì–´ë‚¨.
	- í€´ë†€ë¡  â†’ ë‚´ì„±ì´ ì˜ ìƒê¹€. uncomplicated ë”°ìœ„ì˜ ë³‘ì— ë„ˆë¬´ ë§‰ ì“°ë©´ ë‹¤ë¥¸ í•„ìš”í•œ ë³‘ì— ì“¸ ìˆ˜ ì—†ì„ì§€ë„.

#### Recurrent & Complicated Bacterial cystitis
- 2ì£¼ ì •ë„ ì§€ì¼œë³´ë©° ì¨ë¼.
- í•­ìƒì œë¥¼ ì ì ˆíˆ ì„ íƒí•˜ëŠ” ê²ƒì´ ì¤‘ìš”.
- ì¬ë°œì„± â†’ ì €í•­ì„± ê³ ë ¤í•˜ì—¬, monitoring ì‹œê¸°ë‚˜ ì¹˜ë£Œ ë°˜ì‘ ê¸°ê°„ì„ ê¸¸ê²Œ ë³¼ í•„ìš”ê°€ ìˆìŒ.
- í•­ìƒì œê°€ ì§„ì§œ ì•ˆ ë“£ëŠ” ê²½ìš°, ë³´ì¡° ìš”ë²•ì„ ì‚¬ìš©í•  ìˆ˜ ìˆìŒ.
	- 'ë³´ì¡° ìš”ë²•'ì¸ ë§Œí¼, ë‹¨ë…ìœ¼ë¡œ ì¹˜ë£Œí•˜ê¸°ì—” ì ì ˆí•˜ì§€ ì•ŠìŒ.
- ê°œì˜ í”¼ë¶€ëŠ” ì—¼ê¸°ì„±/ì¤‘ì„±ì¸ ê²½ìš° ë§ìŒ. í”¼ë¶€ì— ì„¸ê·  ê°ì—¼ì´ ì˜ ìƒê¹€.
- ë¹„ë‡¨ê¸°ê³„ë„ ì‚¬ëŒë³´ë‹¤ ê°œì—ì„œ acidicí•˜ê²Œ ì†Œë³€ì„ ë°”ê¾¸ëŠ” ê²Œ ì–´ë ¤ì›Œì„œ, ë³´ì¡°ì œ íš¨ê³¼ê°€ ì‚¬ëŒì— ë¹„í•´ ì•½í•¨.
- ì†Œë³€ì´ ë„ˆë¬´ ì‚°ì„±ì´ ë˜ë©´ í•­ìƒì œ responseê°€ ì €í•˜

>[!note] Cranberry proanthocyanidins (PACs)
>- ê°œë‚˜ ê³ ì–‘ì´ê°€ í¬ëœë² ë¦¬ ë§›ì„ ì¢‹ì•„í•˜ì§€ ì•Šì•„, íŒŒìš°ë” ì œì œë¡œ ì‚¬ìš©
>- ëŒ€ì¥ê· ì˜ ë¶€ì°©ì„ ì–µì œí•˜ëŠ” íš¨ê³¼ê°€ ìˆë‹¤.

### Treatment failure
>[!danger] ì¹˜ë£Œ ì‹¤íŒ¨ì˜ ì´ìœ 
>- ë¶€ì ì ˆí•œ ì¹˜ë£Œ
>- Impaired action of drugs (ë³´í˜¸ìê°€ ì•½ì„ ì˜ ë¨¹ì´ì§€ ì•Šì•„ì„œ)
>	- ì • ì–´ë ¤ìš°ë©´ 2ì£¼ ì •ë„ ê°€ëŠ” ì£¼ì‚¬ ì œì œë¡œ êµì²´ ë“±
>- ë‚´ì„± ê²¬ì£¼, 
>- **AMR (antimicrobial resistance)** : í•­ìƒì œ ì €í•­ì„± ì‹¬ê°
>	- MDR (Multidrug-resistant) bacteria : 3ê°œ ì´ìƒì˜ ì¹´í…Œê³ ë¦¬ì— ê°ìˆ˜ì„± ìˆëŠ” ê²Œ í•œë‘ê°œëŠ” ìˆìŒ. (í€´ë†€ë¡  ì œì œ, ë“±)
>	- XDR (Extensively drug-resistant) bacteria : ê·¸ë³´ë‹¤ ë‚´ì„± íŒ¨í„´ì´ ë” ê°•í•¨.
>	- PDR (Pandrug-resistant) bacteria : ì‚¬ëŒì—ì„œë§Œí¼ ë§ì§€ëŠ” ì•ŠìŒ. 
>- Î²-lactam ê³„ì—´ íš¨ê³¼ ì—†ë‹¤ê³  ì•Œë ¤ì§.
>- Carbapenem : 
>- í€´ë†€ë¡  ì œì œ, amino, carbapenem ë“±


### Pyelonephritis
- ì¡°ì§ ì¹¨íˆ¬ë ¥
- ìˆ˜ì•¡ ì¡°ì¹˜ê°€ ì¹˜ë£Œì— ì¢‹ìŒ
- í€´ë†€ë¡  ì œì œ, ì—†ìœ¼ë©´ amoxicillin
- cefovecin

- ì ˆì œê°€ ë” ê·¼ë³¸ì ì¸ ì¹˜ë£Œ
- ì‹ ìš°ì‹ ì—¼, ë°©ê´‘ì—¼ì— ë¹„í•´ ì¢€ ë” ì¹¨íˆ¬ë ¥ì´ ì¢‹ì€ ì•½ë¬¼ì´ í•„ìš”í•¨.

### Bacterial prostatitis
ëª¨ë‹ˆí„°ë§
- Urine culture
- ì „ë¦½ì„ ì•¡ culture ì‹œ ì‹¤ì§ˆì´ ì„ì—¬ ìˆì„ ìˆ˜ ìˆìœ¼ë¯€ë¡œ, 


# 6. ì˜ˆí›„



# 7. ì˜ˆë°©
- Catheterizaiton ì‹œ ì˜ˆë°©ì  í•­ìƒì œ/ê°ì—¼ ëª¨ë‹ˆí„°ë§
- ì„¸ê· ì´ ë” ì´ìƒ ì•ˆ 
- ì €ìš©ëŸ‰ í•­ìƒì œ ëŠìœ¼ë©´ ë°”ë¡œ ì¬ë°œ 
- í”„ë¡œí† ì½œì´ ëª…í™•í•˜ì§€ ì•Šìœ¼ë¯€ë¡œ, íš¨ëŠ¥ í‰ê°€ê°€
- ë‹¤ë‹¹ë¥˜ : ì„¸ê· ì˜ ë¶€ì°© ì–µì œ,-